Exosomes 2020
DOI: 10.1016/b978-0-12-816053-4.00020-1
|View full text |Cite
|
Sign up to set email alerts
|

The potential of exosomes as theragnostics in various clinical situations

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
9
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 16 publications
(9 citation statements)
references
References 127 publications
(136 reference statements)
0
9
0
Order By: Relevance
“…5 Lately, exosomal proteins and nucleic acids have received particular attention in several studies exploring the biological processes in which they are involved with therapeutic purposes. [6][7][8] However, exosomal lipids represent other less-explored bioactive molecules abundantly present in exosomes, not only as part of their structure but also exerting regulatory functions in receptor cells. 9 Figure 1 shows the number of scientific publications indexed in PubMed related to exosome genomics, proteomics and lipidomics between 2000 and 2019.…”
mentioning
confidence: 99%
“…5 Lately, exosomal proteins and nucleic acids have received particular attention in several studies exploring the biological processes in which they are involved with therapeutic purposes. [6][7][8] However, exosomal lipids represent other less-explored bioactive molecules abundantly present in exosomes, not only as part of their structure but also exerting regulatory functions in receptor cells. 9 Figure 1 shows the number of scientific publications indexed in PubMed related to exosome genomics, proteomics and lipidomics between 2000 and 2019.…”
mentioning
confidence: 99%
“…Those reports are consistent with our present studies. Previous studies also demonstrated that exosomes serve as therapeutic biomarkers in SARS-CoV-infected patients ( Kang, 2020 ; Zheng et al, 2020 ). SARS-CoV-2 regulates signal transduction, metabolism in mitochondria, and apoptosis of host cells ( Guzzi et al, 2020 ).…”
Section: Discussionmentioning
confidence: 89%
“…Furthermore, priming with the S-protein exosome vaccine and subsequent boosting via the addition of the adenoviral vector vaccine yielded neutralizing antibody titers exceeding those of a SARS-convalescent patient serum [ 125 , 130 ]. This exosome-based vaccine is an excellent example demonstrating the possibilities of exosomes as nanotherapeutics.…”
Section: Role Of Evs In the Pathogenesis Of Viral Infectionsmentioning
confidence: 99%